Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Acquisitions & Divestments (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Change in Acquisitions & Divestments data on record, last reported at $61.9 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 5.78% year-over-year to $61.9 million; the TTM value through Dec 2025 reached $312.7 million, up 154.19%, while the annual FY2025 figure was $312.7 million, 154.19% up from the prior year.
  • Change in Acquisitions & Divestments reached $61.9 million in Q4 2025 per PRAX's latest filing, down from $125.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $125.5 million in Q3 2025 and bottomed at $3.0 million in Q2 2024.
  • Average Change in Acquisitions & Divestments over 4 years is $50.4 million, with a median of $58.5 million recorded in 2024.
  • Peak YoY movement for Change in Acquisitions & Divestments: tumbled 85.71% in 2023, then soared 1876.57% in 2025.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $22.6 million in 2022, then tumbled by 77.87% to $5.0 million in 2023, then surged by 1070.0% to $58.5 million in 2024, then grew by 5.78% to $61.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $61.9 million in Q4 2025, $125.5 million in Q3 2025, and $59.3 million in Q2 2025.